Archives: News | Page 2 | Labquality Days

21.1.2018

Reference methods in clinical chemistry and laboratory medicine

Abstract: Reference measurement procedures – Emphasis on performance specifications and operating laboratories In the discipline of laboratory medicine there is consensus that routine measurement procedures/assays claiming the same measurand should give equivalent results within clinically meaningful limits, and that trueness is the ideal basis for achieving equivalence. This measurement paradigm was already propagated by … Continued

19.1.2018

Requirements of traceability in the new in vitro diagnostic directive

Abstract: Traceability and the New EU IVD Regulation Patients naturally expect all results of all laboratory tests to be accurate, equivalent across time and geography and interpreted in the same way by all clinicians. Since none of these expectations is true, it is incumbent on our profession to address this matter with urgency. As … Continued

16.1.2018

Standardization and harmonization of the total laboratory examination process

Abstract: Standardization and Harmonization in Laboratory Medicine: A Matter of Patient Safety Standardization and harmonization initiatives in laboratory medicine should include all aspects of the total examination process, from the “pre-pre-analytical” phase through analysis to the “post-post-analytical” phase. Rapidly available and precise results can indeed be of very limited value if they cannot be … Continued

Analytical quality specifications - Labquality Days 2018

13.1.2018

How to set analytical performance specifications in laboratory medicine?

Abstract: Performance Specifications with Special Emphasis on Biological Variation Data How to set analytical performance specifications was discussed on the 1th Straategic conference of EFLM in Milan 2014. Four models were recommended: Model 1: Based on the effect of analytical performance on clinical outcomes. Model 2. Based on components of biological variation of the … Continued

New glucose strategy - Labquality Days 2018

10.1.2018

Alternative Glucose Monitoring Strategy

Abstract – Labquality Days 2018 The FreeStyle Libre Flash Glucose Monitoring System – enriched opportunities in diabetes management The prevalence of diabetes is achieving epidemic proportions and a multifactorial approach is required to reduce the risk of complications and consequent morbidity and mortality. Glycemic control remains key to reducing microvascular complications and long-term macrovascular … Continued

Visitors from 40 countries - Labquality Days 2018

6.1.2018

Medical Laboratory Professionals from 40 Countries

International Congress on Quality in Laboratory Medicine 8-9 February, 2018 The 2018 congress has already attracted medical laboratory and quality management professionals form 40 countries to Helsinki to participate to the most interesting congress on laboratory medicine and healthcare technology field in Europe. The scientific program deals with quality issues of laboratory medicine and … Continued

EDTA tubes with heart - Labquality Days 2018

3.1.2018

Challenge of Improved Outcomes in Diabetes Care

Abstract – www.labqualitydays.com Role of Laboratories Timo Kouri, MD PhD, Senior Physician (HUS) Role of clinical laboratories is focused on accuracy and traceability of multiple measurements used to treat diabetes patients. This activity is officially described in ISO 15189:2013 standard (Medical laboratories. Requirements for quality and competence), and a parallel ISO 22870:2016 standard (Point-of-care … Continued

31.12.2017

Labquality Days has 1500 followers on Twitter

Follow us on Twitter #LQD2018 You can find the International Congress on Quality in Laboratory Medicine from Twitter by @LabqualityDays. We have already more than 1500 followers on Twitter and the community is growing fast. Join us and get updated by the latest news and related activities. The official hashtag for the 2018 congress … Continued

29.12.2017

Pharmacogenetics: do you have your DNA passport?

Abstract Adverse drug reactions are a major problem in todays medicine: it is responsible for 5-7% of hospitalizations. A substantial part of this is due to interindividual variation in drug metabolism: the same drug dose will result in different blood concentrations and thus different outcomes in patients. Predicting the capacity of patients to metabolize drugs, … Continued

22.12.2017

New trends in Alzheimer disease management

Abstact The identification and validation of biomarkers for diagnosing Alzheimer’s disease (AD) and other forms of dementia are critically important. Until now ELISA measurement of β-amyloid(1–42), total Tau and phospho-Tau (181P) in cerebrospinal fluid (CSF) were the most advanced and accepted method to diagnose probable AD with high specificity and sensitivity. Today automated assays … Continued